Health
Researchers launch randomized, placebo-controlled clinical trial of pulmozyme in COVID-19 patients – News-Medical.Net
Researchers at Boston Children’s Hospital and Brigham and Women’s Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventil…
Researchers at Boston Children’s Hospital and Brigham and Women’s Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation.
The study aims to enroll 60 adults and children (over age 3) admitted to intensive care units.
Dornase alfa, also called DNase 1, is FDA-approved for patients with cystic fibrosis, to break up thick mucus secretions and prevent lung…
-
Noosa News12 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General9 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News11 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Noosa News10 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor